The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Regulatory News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.00
Bid: 31.80
Ask: 32.90
Change: 0.00 (0.00%)
Spread: 1.10 (3.459%)
Open: 32.90
High: 33.00
Low: 31.90
Prev. Close: 33.00
EKF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

16 Jul 2012 15:05

RNS Number : 7705H
EKF Diagnostics Holdings PLC
16 July 2012
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

EKF DIAGNOSTICS HOLDINGS PLC

2. Reason for the notification  (please tick the appropriate box or boxes)

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify): ___________

3. Full name of person(s) subject to the notification obligation:

Ignis Investment Services Limited

4. Full name of shareholder(s) (if different from 3.):

5. Date of the transaction and date on which the threshold is crossed or reached if different:

11/07/2012

6. Date on which issuer notified:

12/07/2012

7. Threshold(s) that is/are crossed or reached:

4%

 

 

8.Notified details: Nominee holdings

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights viii

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

3150980

9,830,731

3.87%

 

B: Financial Instruments

 

Resulting situation after the triggering transaction xii

 

Type of financial instrument

Expiration date

Exercise/ Conversion Period/ Date

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration Date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

Nominal

Delta

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

9,830,731.00

3.87%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 

Vidacos Nominees Ltd (9,830,731.00 3.87%)

Phoenix Group Holdings

Impala Holdings Limited

Ignis Asset management Ltd

Ignis Investment Services Ltd (indirect)

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

Percentage calculation based on Issued Share Capital of 253879110

14. Contact name:

Jean Birrell

15. Contact telephone number:

0141 222 8226

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUNRSRUUABAAR
Date   Source Headline
13th May 20137:00 amRNSFirst PointMan DNA enrichment products launched
15th Apr 20131:34 pmRNSPublication of Annual Report & Notice of AGM
18th Mar 20137:00 amRNSFinal Results
4th Mar 20137:00 amRNSEstablishment of EKF Molecular & Acquisition
18th Jan 20137:00 amRNSPre-close Trading Update
21st Dec 20123:53 pmRNSDirectors' Exercise of Options
17th Dec 20127:00 amRNSHolding(s) in Company
27th Nov 20124:32 pmRNSHolding(s) in Company
9th Nov 20127:00 amRNSIssue of Equity
24th Sep 20127:00 amRNSHalf Yearly Report
5th Sep 20127:00 amRNSTrading Update
14th Aug 20127:00 amRNSNICE guidance on type 2 diabetes
10th Aug 20127:00 amRNSHemoCue settlement agreement
17th Jul 20127:00 amRNSLicensing agreement for kidney markers
16th Jul 20123:05 pmRNSHolding(s) in Company
16th Jul 20127:00 amRNSQuo-Lab CE marking & Commercial launch
12th Jul 20121:11 pmRNSHolding(s) in Company
28th Jun 20127:00 amRNSDirector's Share Options
26th Jun 201210:30 amRNSHolding(s) in Company
23rd May 20121:00 pmRNSResult of AGM
11th May 20127:00 amRNSUpdate on Disposal of IBL AG
20th Apr 201211:18 amRNSPublication of Annual Report & Notice of AGM
18th Apr 20124:50 pmRNSHolding(s) in Company
5th Apr 20127:00 amRNSDirectors' Exercise of Options
5th Apr 20127:00 amRNSChina Patent Grant
3rd Apr 20121:47 pmRNSHolding(s) in Company
27th Mar 20127:00 amRNSDisposal of International Brand Licensing AG
26th Mar 20128:18 amRNSAdviser Change of Name
21st Mar 20127:00 amRNSFinal Results
20th Mar 20127:00 amRNSAppointment of Group Head of Sales
16th Mar 20127:00 amRNSTrading Update & Notice of Final Results
8th Mar 20127:00 amRNSUS Patent Grant
6th Feb 20127:00 amRNSNew US contract win
30th Jan 20122:08 pmRNSHolding(s) in Company
19th Jan 20127:00 amRNSPre-Close Trading Update
30th Nov 20117:00 amRNSContract win
29th Nov 20117:00 amRNSUpdate on US market expansion
24th Oct 20115:53 pmRNSHolding(s) in Company
24th Oct 20115:51 pmRNSHolding(s) in Company
12th Oct 201112:42 pmRNSHolding(s) in Company
7th Oct 20113:44 pmRNSHolding(s) in Company
29th Sep 20115:14 pmRNSHolding(s) in Company
28th Sep 20117:01 amRNSDirectorate Change
28th Sep 20117:00 amRNSHalf Yearly Report
27th Sep 20117:00 amRNSChange of Adviser
23rd Sep 20111:26 pmRNSNotice of Results
6th Jul 20113:48 pmRNSResult of AGM
29th Jun 20119:45 amRNSDirectors' Dealings
22nd Jun 20117:00 amRNSHolding(s) in Company
20th Jun 201111:37 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.